Kabilan K L/LinkedIn
May 28, 2026, 12:36
Kabilan K L: Key Nursing Considerations for Abciximab Therapy
Kabilan K. L., Pediatric Cardiac ICU Nurse at Alemeis Hospital, shared a post on LinkedIn:
“455 | Abciximab (Abcixirel)
Abciximab is a monoclonal antibody antiplatelet agent used intravenously in high-risk patients undergoing PCI.
Mechanism of action
- Fab fragment of immunoglobulin
- Blocks glycoprotein IIb/IIIa receptors on platelets
- Inhibits platelet aggregation
- Helps prevent thrombus formation
Indication
- Used as an adjunct with aspirin and heparin
- High-risk patients undergoing percutaneous coronary intervention (PCI)
- Effects may last 24–48 hours after infusion
Dosage
- Initial loading: 250 mcg/kg IV bolus
- Infusion before angioplasty: 125 ng/kg/min, max 10 mcg/min
- Infusion after angioplasty: continue as per protocol, commonly up to 12 hours
Side effects
- Bleeding
- Hypotension
- Nausea
- Bradycardia
- Rare thrombocytopenia
Nursing responsibilities
- Monitor for bleeding from IV site, gums, urine, stool, and puncture sites
- Check platelet count and coagulation profile as ordered
- Monitor BP, HR, and ECG
- Avoid unnecessary IM injections
- Apply firm pressure after sheath removal
- Educate patient to report bleeding, dizziness, or black stools
Key point
Abciximab is a potent antiplatelet drug for high-risk PCI patients.
Use with caution and monitor closely for bleeding.
Stay Consistent!”
Stay updated with Hemostasis Today.
-
May 28, 2026, 12:17Astha Thakkar: Practical Approaches to Platelet Thresholds in ITP
-
May 28, 2026, 09:16Maxime Dely: The Human Connection Behind Stem Cell Donation
-
May 28, 2026, 09:15Heghine Khachatryan: Maternal Health Begins With Recognizing Iron Deficiency Early
-
May 28, 2026, 09:15Alejandro González Veliz: Why Cardiovascular Prevention Matters More Than Intervention
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79